JP2008509224A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509224A5
JP2008509224A5 JP2007525717A JP2007525717A JP2008509224A5 JP 2008509224 A5 JP2008509224 A5 JP 2008509224A5 JP 2007525717 A JP2007525717 A JP 2007525717A JP 2007525717 A JP2007525717 A JP 2007525717A JP 2008509224 A5 JP2008509224 A5 JP 2008509224A5
Authority
JP
Japan
Prior art keywords
medicament
hydroxytyrosol
homocysteine
subject
rich
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007525717A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509224A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/028179 external-priority patent/WO2006020588A1/en
Publication of JP2008509224A publication Critical patent/JP2008509224A/ja
Publication of JP2008509224A5 publication Critical patent/JP2008509224A5/ja
Pending legal-status Critical Current

Links

JP2007525717A 2004-08-09 2005-08-09 炎症状態を治療するためのオリーブ組成物及び方法 Pending JP2008509224A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60023804P 2004-08-09 2004-08-09
US67246005P 2005-04-18 2005-04-18
PCT/US2005/028179 WO2006020588A1 (en) 2004-08-09 2005-08-09 Olive compositions and methods for treating inflammatory conditions

Publications (2)

Publication Number Publication Date
JP2008509224A JP2008509224A (ja) 2008-03-27
JP2008509224A5 true JP2008509224A5 (cg-RX-API-DMAC7.html) 2008-10-02

Family

ID=35907742

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007525717A Pending JP2008509224A (ja) 2004-08-09 2005-08-09 炎症状態を治療するためのオリーブ組成物及び方法

Country Status (3)

Country Link
US (2) US20080300198A1 (cg-RX-API-DMAC7.html)
JP (1) JP2008509224A (cg-RX-API-DMAC7.html)
WO (1) WO2006020588A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090076142A1 (en) * 2005-05-09 2009-03-19 The Trustees Of The University Of Pennsylvania Use of the irritating principal oleocanthal in olive oil, as well as structurally and functionally similar compounds
US9789149B2 (en) 2005-07-19 2017-10-17 Creagri, Inc. Vegetation water composition for treatment of inflammatory skin conditions
JP5339373B2 (ja) * 2006-07-14 2013-11-13 ディーエスエム アイピー アセッツ ビー.ブイ. 組成物および炎症障害の治療、共治療または予防のためのその使用
JP5175481B2 (ja) * 2006-10-23 2013-04-03 エーザイフード・ケミカル株式会社 軟骨再生促進剤
JP2008120716A (ja) * 2006-11-10 2008-05-29 Eisai Food Chemical Kk 抗炎症剤
WO2008128552A1 (en) * 2007-04-18 2008-10-30 Dsm Ip Assets B.V. Novel use of hydroxytyrosol and olive extracts/concentrates containing it
EP1982706A1 (en) * 2007-04-18 2008-10-22 DSMIP Assets B.V. Use of hydroxytyrosol for the treatment of cartilage injury
CN101945651A (zh) * 2007-12-12 2011-01-12 帝斯曼知识产权资产管理有限公司 包含羟基酪醇和软骨素的组合物及其用于治疗、辅助治疗或预防炎性病症的用途
US8796315B2 (en) 2009-06-25 2014-08-05 Darlene E. McCord Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
WO2010151778A2 (en) 2009-06-25 2010-12-29 Darlene Mccord Topical compositions and methods for wound care
CA2769819C (en) 2009-08-10 2015-07-21 Darlene Mccord Nutritional supplements
EP2925307B1 (en) 2012-11-30 2020-10-28 McCord, Darlene E. Hydroxytyrosol and oleuropein compositions for induction of dna damage, cell death and lsd1 inhibition
WO2014100715A2 (en) * 2012-12-21 2014-06-26 Ehrenkranz Joel R L Supplements and monitoring systems for dosing of the supplements
ITMI20131815A1 (it) * 2013-10-31 2015-05-01 Fattoria La Vialla Di Gianni Anton Io E Bandino L Uso antinfiammatorio di fitocomplessi liquidi da olive
CA2962487A1 (en) * 2014-09-24 2016-03-31 Phytogen Medical Foods S.L Pharmaceutical product, medical food or dietary supplement for preventing cancer and inflammatory diseases
GR1008734B (el) 2014-11-26 2016-04-05 ΚΡΕΤΑ ΦΑΡΜ ΑΝΩΝΥΜΟΣ ΒΙΟΜΗΧΑΝΙΚΗ ΚΑΙ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ με δ.τ. "ΚΡΕΤΑ ΦΑΡΜ Α.Β.Ε.Ε." Υδατικο εκχυλισμα ελιας με μεταβολικες και καρδιο-προστατευτικες ιδιοτητες.
JP5956669B1 (ja) * 2015-12-18 2016-07-27 サンスター株式会社 低カロリーチョコレート組成物
US10342802B2 (en) 2016-10-04 2019-07-09 Nutramax Laboratories, Inc. Compositions comprising hydroxytyrosol and boswellic acid
CN109789110A (zh) * 2016-10-04 2019-05-21 纽崔玛氏科技有限责任公司 包含羟基酪醇和乳香酸的组合物
US11007171B2 (en) * 2017-07-13 2021-05-18 Summit Innovation Labs, LLC Treatment and prevention of joint disorders
EP3706759B1 (en) * 2017-11-08 2023-11-15 Société des Produits Nestlé S.A. Homovanillyl alcohol (hva), hva isomer, methods of making compositions comprising such compounds, and methods using such compounds
JP2020193852A (ja) * 2019-05-28 2020-12-03 株式会社ファンケル 非侵襲的な血清亜鉛値の推定方法
EP4216735A1 (en) * 2020-09-24 2023-08-02 Mars Incorporated Food compositions and applications thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522119A (en) * 1980-12-23 1985-06-11 Fps Development Partnership Olive oil recovery
US4452744A (en) * 1980-12-23 1984-06-05 Fps Development Partnership Olive oil recovery
US4370274A (en) * 1980-12-23 1983-01-25 Fps Development Partnership Olive oil recovery
ATE123287T1 (de) * 1991-03-21 1995-06-15 Dior Christian Parfums Kaffeinsaure-derivate,oraposid,ihre kosmetische oder pharmazeutische zusammensetzungen,insbesondere mit dermatologischer wirkung.
WO1996014064A1 (en) * 1994-11-07 1996-05-17 Strecker, Robert, B. Method and composition for antiviral therapy
US5998641A (en) * 1997-01-31 1999-12-07 Unilever Patent Holdings Debittering of olive oil
US5714150A (en) * 1997-01-08 1998-02-03 Nachman; Leslie Method for producing extract of olive leaves
US6984667B2 (en) * 1998-04-08 2006-01-10 Theta Biomedical Consulting And Development Co. Synergistic proteoglycan compositions for inflammatory conditions
DE69902645T2 (de) * 1998-04-14 2003-04-30 Unilever N.V., Rotterdam Verstärkung von pflanzlichem fett mit antioxidantien
US6936287B1 (en) * 1998-07-23 2005-08-30 Creagri, Inc. Water-soluble extract from olives
US6197308B1 (en) * 1998-07-23 2001-03-06 Creagri L.L.C. Water-soluble extract from olives
US6165475A (en) * 1998-07-23 2000-12-26 Creagri, Inc. Water-soluble extract from olives
EP1139797A2 (en) * 1998-12-22 2001-10-10 Unilever N.V. Food compositions fortified with anti-oxidants
KR20020063877A (ko) * 1999-10-14 2002-08-05 니신 오일 밀스 가부시키가이샤 피부개선제, 피부노화 방지제, 미백제 및 피부외용제
US6358542B2 (en) * 1999-12-20 2002-03-19 Usana, Inc. Antioxidant compositions extracted from olives and olive by-products
AU2000258901A1 (en) * 2000-04-06 2001-10-23 Nicholas V. Perricone Treatment of skin damage using olive oil polyphenols
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
US7713569B2 (en) * 2000-09-01 2010-05-11 Creagri, Inc. Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof
WO2002018310A1 (en) * 2000-09-01 2002-03-07 Creagri, Inc. Method of obtaining a hydroxytyrosol-rich composition from vegetation water
PT1369407E (pt) * 2001-02-15 2009-01-22 Consejo Superior Investigacion Processo de obtenção de hidroxitirosol purificado a partir de produtos e subprodutos derivados da oliveira
US6734449B2 (en) * 2001-11-20 2004-05-11 Nexpress Solutions Llc Device for detecting the location of an edge of a transparent material, web edge control and printing press
WO2003066034A2 (en) * 2002-02-08 2003-08-14 Lavipharm S.A. Use of compounds and compositions derived form olives for protecting cells against dna damage
WO2003068171A2 (en) * 2002-02-13 2003-08-21 Creagri, Inc. Method and composition for treatment of inflammation and aids-associated neurological disorders
US6743449B2 (en) * 2002-02-13 2004-06-01 Skinceuticals, Inc. Topical composition comprising olive leaf extract
ES2193874B1 (es) * 2002-04-03 2005-03-01 Puleva Biotech, S.A. Compuestos naturales y derivados de estos para la prevencion y el tratamiento de enfermedades cardiovasculares, hepaticas, renales y cosmeticas.
US20050113287A1 (en) * 2003-10-21 2005-05-26 Motion Potion, Inc. Composition to enhance joint function and repair

Similar Documents

Publication Publication Date Title
JP2008509224A5 (cg-RX-API-DMAC7.html)
GB0410266D0 (en) Treatment of apoptosis
EP4582099A3 (en) Methods of treating inflammatory and autoimmune diseases with natalizumab
JP2002522485A5 (cg-RX-API-DMAC7.html)
CN107308161A (zh) 左西替利嗪和孟鲁司特在治疗流感、普通感冒和炎症中的用途
NZ613291A (en) Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
JP2017510607A5 (cg-RX-API-DMAC7.html)
RU2009119258A (ru) Способ лечения воспалительных заболеваний кишечника
JP2020500864A5 (cg-RX-API-DMAC7.html)
Troester et al. Pediatric sleep pharmacology: a primer
Niino et al. Optimal clinical pathway for the patient with type B acute aortic dissection
RU2006139819A (ru) Применение симетикона для предрасположенных к запорам пациентов
Wawrzyniak et al. Comparison of clonidine and midazolam premedication before endoscopic sinus surgery: results of clinical trial
JP2024026871A (ja) 慢性便秘症を治療するための医薬組成物
WO2004017973A1 (ja) 統合失調症治療剤
Prousky The use of Niacinamide and Solanaceae (Nightshade) Elimination in the Treatment of Osteoarthritis.
WO2020104987A1 (en) Composition for use in the prevention and/or symptomatic treatment of irritable bowel syndrome
US10179122B2 (en) Use of melatonin
US20220370347A1 (en) Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
JP2007112795A (ja) アントラキノン系薬剤含有下剤医薬組成物
JP2006282507A (ja) 下痢の予防および/または治療薬
JP6032681B2 (ja) 排尿障害の予防・治療剤
WO2006011495A1 (ja) 高コレステロール血症及び/又は高トリグリセリド血症治療剤
Botea Analgesics
Daneel Neulactil (pericyazine) in the behaviour disturbances of institutionalized mental defectives